or
forgot password

    • cancer clinical trials in glendale, CA

    • Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
    Glendale Memorial Hospital Comprehensive Cancer Center
    Glendale, California 91204
    Lung Cancer
    S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
    Glendale Memorial Hospital Comprehensive Cancer Center
    Glendale, California 91204
    Breast Cancer
    Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
    Glendale Memorial Hospital Comprehensive Cancer Center
    Glendale, California 91204
    Breast Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
    Comprehensive Cancer Center
    Glendale, California 91204
    Small Cell Lung Cancer
    Study of Recombinant Human Thrombin for Bleeding During Surgery
    Glendale Adventist Medical Center
    Glendale, California 91206
    Surgical Hemostasis
    Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)
    Comprehensive Cancer Center
    Glendale, California 91204
    Unresectable Stage III or IV Malignant Melanoma
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    Comprehensive Cancer Center-Research Office
    Glendale, California 91204
    NSCLC
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Glendale Memorial Hospital & Health Center
    Glendale, California
    Breast Neoplasms, Neoplasm Metastasis
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Glendale Memorial Hospital and Health Center
    Glendale, California 91204
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    Glendale Memorial Hospital and Health Center
    Glendale, California 91204
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    A Safety and Efficacy Study in Patients With Gastric Cancer
    Comprehensive Cancer Center
    Glendale, California 91204
    Gastric Cancer
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Innovative Cancer Research Consortium
    Glendale, California 91206
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Glendale Memorial Hospital Comprehensive Cancer Center
    Glendale, California 91204
    Prostate Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    John J. Guagenti, MD
    Glendale, California 91204
    Psoriasis
    A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
    Glendale Memorial Hospital
    Glendale, California 91204
    Acute Myeloid Leukemia
    Cognition in the Study of Tamoxifen and Raloxifene
    Glendale Memorial Hospital Comprehensive Cancer Center
    Glendale, California 91204
    Cognition, Aging
    S0916, MLN1202 in Treating Patients With Bone Metastases
    Glendale Memorial Hospital Comprehensive Cancer Center
    Glendale, California 91204
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific